Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.885 USD | -3.33% | -5.50% | -87.16% |
Apr. 11 | Baird Trims Amylyx Pharmaceuticals' Price Target to $3 From $4, Maintains Neutral Rating | MT |
Apr. 10 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.16% | 132M | |
-2.86% | 87.37B | |
+3.95% | 41.01B | |
-22.19% | 28.08B | |
+53.11% | 24.72B | |
-5.12% | 17.47B | |
-44.23% | 11.69B | |
-18.00% | 11.6B | |
-13.96% | 11.56B | |
-0.22% | 8.44B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Citigroup Raises Amylyx Pharmaceuticals Price Target to $50 From $48, Maintains Buy Rating